# Syngene International Ltd., Bengaluru, India – FDA Inspections

Source: https://www.keypedia.com/companies/syngene-international-ltd/11ddfe19-cf6b-48b5-b7ab-8e3236ac3636

> Inspection records and compliance data for Syngene International Ltd. in Bengaluru. 6 FDA inspections on record, 1 Form 483, last inspected February 20, 2025.

---

## Details

- Name: Syngene International Ltd.
- FEI Number: 3003600340
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE
- Address Line 1: Biocon Sez, Biocon Park, Plot No. 2, 3, 4 & 5, Bommasandra Industrial Park, Jigani Link Road
- City: Bengaluru
- Country Name: India
- Address: Biocon Sez, Biocon Park, Plot No. 2, 3, 4 & 5, Bommasandra Industrial Park, Jigani Link Road, Bengaluru, India
- Country: India

## Related Documents

- [483 - Syngene International Ltd. - 2025-02-20](https://www.keypedia.com/records/483/syngene-international-ltd/0399825e-1d13-4206-b368-94c7a473c188) — source: FDA, date: February 20, 2025
- FDA Inspection 1267516 - Syngene International Ltd. - 2025-02-20 — source: FDA, date: February 20, 2025
- [FDA Inspection 1267516 - Syngene International Ltd. - 2025-02-20](https://www.keypedia.com/records/fda_inspections/syngene-international-ltd/e53f5132-0908-4433-8fe6-873789f19a38) — source: FDA, date: February 20, 2025
- FDA Inspection 1267516 - Syngene International Ltd. - 2025-02-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 20, 2025
- FDA Inspection 1267516 - Syngene International Ltd. - 2025-02-20 — classification: No Action Indicated (NAI), source: FDA, date: February 20, 2025
- FDA Inspection 1267516 - Syngene International Ltd. - 2025-02-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 20, 2025
- FDA Inspection 1193108 - Syngene International Ltd. - 2022-11-15 — classification: No Action Indicated (NAI), source: FDA, date: November 15, 2022
- FDA Inspection 1103377 - Syngene International Ltd. - 2019-08-21 — classification: No Action Indicated (NAI), source: FDA, date: August 21, 2019
- FDA Inspection 1056484 - Syngene International Ltd. - 2018-04-27 — source: FDA, date: April 27, 2018
- FDA Inspection 890834 - Syngene International Ltd. - 2014-07-11 — classification: No Action Indicated (NAI), source: FDA, date: July 11, 2014
- FDA Inspection 849300 - Syngene International Ltd. - 2013-09-18 — classification: No Action Indicated (NAI), source: FDA, date: September 18, 2013

## Related Companies

- [AbbVie Inc.](https://www.keypedia.com/companies/abbvie-inc/404ebab5-56a6-486d-bb01-be43a9478fad)
- [Siegfried USA, LLC](https://www.keypedia.com/companies/siegfried-usa-llc/0e21650d-f620-4e29-a62d-aa4ecd79cef2)
- [Fresenius Kabi AB](https://www.keypedia.com/companies/fresenius-kabi-ab/95acd39b-72be-48a9-aa55-38713a33c8cc)
- [Indena S.p.A.](https://www.keypedia.com/companies/indena-spa/bc7187ac-74c4-4f04-bd1c-0d888424e076)
- [Hovione Limited](https://www.keypedia.com/companies/hovione-limited/cf05e9e2-8ff4-41e2-a547-34c4f03eaef5)
- [FIS - Fabbrica Italiana Sintetici S.p.A.](https://www.keypedia.com/companies/fis-fabbrica-italiana-sintetici-spa/b9e7c30e-9955-4095-aae6-e40efd92c3c0)
- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/a659fe71-9183-4c7c-96ca-9214c6a9c177)
- [Genzyme Flanders](https://www.keypedia.com/companies/genzyme-flanders/5f71d574-8097-4cd8-9254-2f8b85700e59)
- [Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/d07820ec-a994-41cb-b667-509183a6cc4a)
- [Hovione FarmaCiencia SA](https://www.keypedia.com/companies/hovione-farmaciencia-sa/e55a2dd8-7c1c-493d-8511-9761732d75ec)

## Related Officers

- [Investigator](https://www.keypedia.com/people/marcellinus-d-dordunoo/a0e35c24-0cf5-4b11-95ba-1693fa3ecb3a)
- [Mr. Aron Shapiro](https://www.keypedia.com/people/mr-aron-shapiro/4e7e6c39-4aa7-4cdc-8a62-620b3479374c)